Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Paul D. Mintz"'
Autor:
Mikhail Menis, Richard A Forshee, Sanjai Kumar, Stephen McKean, Rob Warnock, Hector S Izurieta, Rahul Gondalia, Chris Johnson, Paul D Mintz, Mark O Walderhaug, Christopher M Worrall, Jeffrey A Kelman, Steven A Anderson
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0140332 (2015)
BackgroundHuman babesiosis, caused by intraerythrocytic protozoan parasites, can be an asymptomatic or mild-to-severe disease that may be fatal. The study objective was to assess babesiosis occurrence among the U.S. elderly Medicare beneficiaries, ag
Externí odkaz:
https://doaj.org/article/c6898cf4314f421fa6f1d17808da63bd
Autor:
Paul D. Mintz, Remo P. Vallejo
Publikováno v:
Journal of Clinical Haematology. 2
Autor:
Paul D, Mintz, Remo P, Vallejo
Publikováno v:
Annals of clinical and laboratory science. 50(5)
Autor:
Paul D. Mintz, Remo P. Vallejo
Publikováno v:
Transfusion. 60(10)
Autor:
Paul D. Mintz, Yli Remo Vallejo
Publikováno v:
Transfusion. 61:1342-1343
Autor:
Paul D. Mintz, Remo P. Vallejo
Publikováno v:
Annals of Blood. 6:19-19
Autor:
Paul D. Mintz, Steven A. Anderson, Hector S. Izurieta, Nandini Selvam, Richard A. Forshee, Bola F. Ekezue, Mikhail Menis, Gayathri Sridhar
Publikováno v:
Transfusion. 58:70-80
BACKGROUND Hemolytic reactions (HRs) are rare serious adverse events after immune globulin (IG) use. Our large claims-based study evaluated occurrence of same-day hemolysis after administration of different IG products and potential risk factors, dur
Autor:
Bola F. Ekezue, Paul D. Mintz, Steven A. Anderson, Nandini Selvam, Mikhail Menis, Hector S. Izurieta, Gayathri Sridhar, Richard A. Forshee
Publikováno v:
Transfusion. 57:2977-2986
BACKGROUND Acute renal failure (ARF) is a rare serious adverse event after immune globulin (IG) use. Our large claims-based study evaluated occurrence of same-day ARF after administration of different IGs and ascertained potential risk factors, durin
Publikováno v:
Concise Guide to Hematology ISBN: 9783319978727
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47d8473649820fbcf5870f1d1816f93e
https://doi.org/10.1007/978-3-319-97873-4_36
https://doi.org/10.1007/978-3-319-97873-4_36
Autor:
Michael Nguyen, Tiffany S. Woodworth, Meghan A Baker, Scott K. Winiecki, Bethany Baer, Wambui Chege, Paul D. Mintz, Christopher Jankosky
Publikováno v:
Transfusion. 55:S28-S35
BACKGROUND Hemolysis after intravenous immune globulins (IGIVs) is a known complication, but expanding indications and recent manufacturing changes warrant ongoing postmarketing surveillance. Characterization of post-IGIV hemolysis to date has been l